CAS 1431525-23-3

Fórmula: C29H24N4O4S

InChI: InChI=1S/C29H24N4O4S/c1-4-27(34)31-26-16-23(12-5-18(26)2)33-28(35)14-9-21-17-30-25-13-8-20(15-24(25)29(21)33)19-6-10-22(11-7-19)32-38(3,36)37/h4-17,32H,1H2,2-3H3,(H,31,34)

Clave InChI: SFMJNHNUOVADRW-UHFFFAOYSA-N

SMILES: CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CC=C(C=C5)NS(=O)(=O)C)NC(=O)C=C

BMX-IN-1

CAS: 1431525-23-3

Fórmula: C₂₉H₂₄N₄O₄S

Pureza: 98%

Forma y color: Solid

Peso molecular: 524.5903

Ref: IN-DA009C9W

BMX-IN-1

CAS: 1431525-23-3

BMX-IN-1

Fórmula: C₂₉H₂₄N₄O₄S

Pureza: ≥98%

Peso molecular: 524.59

Ref: 54-BUP08554

BMX-IN-1

CAS: 1431525-23-3

N-(2-Methyl-5-(9-(4-(methylsulfonamido)phenyl)-2-oxobenzo[h][1,6]naphthyridin-1(2H)-yl)phenyl)acrylamide

Fórmula: C₂₉H₂₄N₄O₄S

Pureza: 98.54%

Peso molecular: 524.59

Ref: IN-DG630272

BMX-IN-1

CAS: 1431525-23-3

BMX-IN-1 is a DNA polymerase inhibitor that has been used in the study of chemical biology. It has been shown to selectively inhibit transcription and replication of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α). The kinetics of BMX-IN-1 have been studied by measuring the inhibition of transcription in vitro. The optimum concentration for BMX-IN-1 was found to be 0.3 μM, which inhibits the synthesis of TNF-α by 58%. BMX-IN-1 also inhibits cancer tissue growth and may be an effective treatment for cancer. This drug is a potential molecular target for cervical cancer.

Fórmula: C₂₉H₂₄N₄O₄S

Pureza: Min. 95%

Peso molecular: 524.59 g/mol

Ref: 3D-GHC52523

BMX-IN-1

CAS: 1431525-23-3

BMX-IN-1 (BMX kinase inhibitor) is a selective inhibitor of bone marrow tyrosine kinase on chromosome X (BMX, IC50 = 8 nM) and the related Bruton’s tyrosine

Fórmula: C₂₉H₂₄N₄O₄S

Pureza: 98.38%

Forma y color: Solid

Peso molecular: 524.59

Ref: TM-T14692